CN100411659C - Chinese medicine for treating aplastic anemia and preparation method thereof - Google Patents
Chinese medicine for treating aplastic anemia and preparation method thereof Download PDFInfo
- Publication number
- CN100411659C CN100411659C CNB2006100096334A CN200610009633A CN100411659C CN 100411659 C CN100411659 C CN 100411659C CN B2006100096334 A CNB2006100096334 A CN B2006100096334A CN 200610009633 A CN200610009633 A CN 200610009633A CN 100411659 C CN100411659 C CN 100411659C
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- fructus
- mel
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a Chinese medicine for treating aplastic anemia and a making method thereof. The Chinese medicine is prepared from prepared rhizome of rehmannia, rehmannia root, milkvetch root, red ginseng, tangshen, hippocampus, desertliving cistanche, barbary wolfberry fruit, dodder, cornus, medicinal indianmulberry root, epimedium herb, common curculigo rhizome, yam, cassia bark, white atractylodes rhizome, flowery knotweed, white peony root, cortex moutan root-bark of tree peony, dried tangerine peel, donkey-hide gelatin, wolfberry bark, cape jasmine fruit, pollen, common anemarrhena rhizome, tortoiseshell, psoralea fruit, dragon bone, oyster shell, liquorice root and honey as the rest. The medicine has outstanding curative effects; when the medicine of the present invention is used for treating aplastic anemia, the effective rate is 91%, the cure rate is 72%, and the ineffective rate is only 9%.
Description
(1) technical field
What the present invention relates to is a kind of medical configuration product, specifically a kind of Chinese medicine that is used for the treatment of aplastic anemia.The present invention also relates to the manufacture method of this Chinese medicine.
(2) background technology
Mainly adopt blood transfusion and male sex hormone drug to control for the treatment of aplastic anemia at present, its curative effect is relatively poor, very easily bounce-back after the drug withdrawal, and the treatment cost is also higher.
(3) summary of the invention
The object of the present invention is to provide the Chinese medicine of the little treatment aplastic anemia of a kind of effective percentage height, side effect.Purpose of the present invention also is to provide a kind of manufacture method of this Chinese medicine.
The object of the present invention is achieved like this:
Per 1000 parts of products are by Radix Rehmanniae Preparata 40-50 part, Radix Rehmanniae 40-50 part, Radix Astragali 45-50 part, Radix Ginseng Rubra 25-30 part, Radix Codonopsis 25-30 part, Hippocampus 15-20 part, Herba Cistanches 20-30 part, Fructus Lycii 20-30 part, Semen Cuscutae 20-30 part, Fructus Corni 25-30 part, Radix Morindae Officinalis 25-30 part, Herba Epimedii 20-30 part, Rhizoma Curculiginis 15-20 part, Rhizoma Dioscoreae 15-30 part, Cortex Cinnamomi 15-20 part, Rhizoma Atractylodis Macrocephalae 15-30 part, Radix Polygoni Multiflori 15-30 part, Radix Paeoniae Alba 20-30 part, Cortex Moutan 25-30 part, Pericarpium Citri Reticulatae 25-30 part, Colla Corii Asini 25-30 part, Cortex Lycii 25-30 part, Fructus Gardeniae 25-30 part, pollen 15-20 part, Rhizoma Anemarrhenae 15-20 part, Carapax et Plastrum Testudinis 15-20 part, Fructus Psoraleae 25-30 part, Os Draconis 40-50 part, Concha Ostreae 40-50 part, the Mel of Radix Glycyrrhizae 20-30 part and surplus is made, and related unit serving is weight portion.
Product of the present invention is to adopt such method to make:
By per 1000 parts of products is by Radix Rehmanniae Preparata 40-50 part, Radix Rehmanniae 40-50 part, Radix Astragali 45-50 part, Radix Ginseng Rubra 25-30 part, Radix Codonopsis 25-30 part, Hippocampus 15-20 part, Herba Cistanches 20-30 part, Fructus Lycii 20-30 part, Semen Cuscutae 20-30 part, Fructus Corni 25-30 part, Radix Morindae Officinalis 25-30 part, Herba Epimedii 20-30 part, Rhizoma Curculiginis 15-20 part, Rhizoma Dioscoreae 15-30 part, Cortex Cinnamomi 15-20 part, Rhizoma Atractylodis Macrocephalae 15-30 part, Radix Polygoni Multiflori 15-30 part, Radix Paeoniae Alba 20-30 part, Cortex Moutan 25-30 part, Pericarpium Citri Reticulatae 25-30 part, Colla Corii Asini 25-30 part, Cortex Lycii 25-30 part, Fructus Gardeniae 25-30 part, pollen 15-20 part, Rhizoma Anemarrhenae 15-20 part, Carapax et Plastrum Testudinis 15-20 part, Fructus Psoraleae 25-30 part, Os Draconis 40-50 part, Concha Ostreae 40-50 part, behind the indispensable good raw material of the parts by weight of Radix Glycyrrhizae 20-30 part and surplus Mel, other raw material mix homogeneously that will be except that Mel, be ground into fine powder, Mel is put into container made of iron, be heated to boiling, other raw material that is ground into fine powder is added in the ebullient Mel, stir, make pill.
Radix Ginseng Rubra among the present invention, the Radix Astragali, Pericarpium Citri Reticulatae, Rhizoma Dioscoreae, Rhizoma Atractylodis Macrocephalae spleen invigorating QI invigorating; Radix Angelicae Sinensis, Colla Corii Asini, the Radix Paeoniae Alba are nourished blood and enrich blood; Herba Cistanches, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Epimedii, Radix Morindae Officinalis warming the kidney to activate YANG; Carapax et Plastrum Testudinis, the Rhizoma Anemarrhenae, pollen, Fructus Gardeniae, Cortex Moutan nourishing YIN for suppressing the hyperactive YANG; Os Draconis, Concha Ostreae tranquillization with heavy prescription reach the irritability bar; Cortex Cinnamomi, Rhizoma Curculiginis, the Radix Polygoni Multiflori, BUSHENZHI tonifying YANG, the kidney invigorating, living marrow; Fructus Lycii, Fructus Corni YANG invigorating benefit is smart, so that interdependence between yin and yang and reach the purpose of the kidney invigorating void.Have only kidney qi abundance, YIN and YANG in a relative equilibrium just can reach treatment anemia purpose.Determined curative effect of the present invention according to Acheng City the People's Hospital Preliminary Clinical Observation, adopts that the effective percentage of product of the present invention treatment aplastic anemia reaches 80%, cure rate reaches 72%, and invalid accounts for 9%.
(4) specific embodiment
For example the present invention is done in more detail below and describes:
By per 1000 parts of products is by Radix Rehmanniae Preparata 40-50 part, Radix Rehmanniae 40-50 part, Radix Astragali 45-50 part, Radix Ginseng Rubra 25-30 part, Radix Codonopsis 25-30 part, Hippocampus 15-20 part, Herba Cistanches 20-30 part, Fructus Lycii 20-30 part, Semen Cuscutae 20-30 part, Fructus Corni 25-30 part, Radix Morindae Officinalis 25-30 part, Herba Epimedii 20-30 part, Rhizoma Curculiginis 15-20 part, Rhizoma Dioscoreae 15-30 part, Cortex Cinnamomi 15-20 part, Rhizoma Atractylodis Macrocephalae 15-30 part, Radix Polygoni Multiflori 15-30 part, Radix Paeoniae Alba 20-30 part, Cortex Moutan 25-30 part, Pericarpium Citri Reticulatae 25-30 part, Colla Corii Asini 25-30 part, Cortex Lycii 25-30 part, Fructus Gardeniae 25-30 part, pollen 15-20 part, Rhizoma Anemarrhenae 15-20 part, Carapax et Plastrum Testudinis 15-20 part, Fructus Psoraleae 25-30 part, Os Draconis 40-50 part, Concha Ostreae 40-50 part, behind the indispensable good raw material of the parts by weight of the Mel of Radix Glycyrrhizae 20-30 part and surplus, other raw material mix homogeneously that will be except that Mel, be ground into fine powder, Mel is put into container made of iron, be heated to boiling, other raw material that is ground into fine powder is added in the ebullient Mel, stir, make pill.
By per 1000 parts of products is by 45 parts in Radix Rehmanniae Preparata, 45 parts in the Radix Rehmanniae, 45 parts of the Radixs Astragali, 30 parts of Radix Ginseng Rubra, 30 parts of Radix Codonopsis, 15 parts of Hippocampus, 25 parts of Herba Cistanches, 25 parts of Fructus Lycii, 25 parts of Semen Cuscutae, 30 parts of Fructus Corni, 25 parts of Radix Morindae Officinaliss, 25 parts of Herba Epimedii, 18 parts of Rhizoma Curculiginises, 20 parts of Rhizoma Dioscoreaes, 18 parts of Cortex Cinnamomis, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of the Radixs Polygoni Multiflori, 25 parts of the Radix Paeoniae Albas, 30 parts of Cortex Moutans, 25 parts of Pericarpium Citri Reticulataes, 25 parts in Colla Corii Asini, 30 parts of Cortex Lycii, 30 parts of Fructus Gardeniaes, 18 parts of pollen, 18 parts of the Rhizoma Anemarrhenaes, 18 parts of Carapax et Plastrum Testudiniss, 30 parts of Fructus Psoraleaes, 45 parts of Os Draconis, 45 parts of Concha Ostreaes, behind the indispensable good raw material of the parts by weight of the Mel of 25 parts in Radix Glycyrrhizae and surplus, other raw material mix homogeneously that will be except that Mel, be ground into fine powder, Mel is put into container made of iron, be heated to boiling, other raw material that is ground into fine powder is added in the ebullient Mel, stir, make pill.
By per 1000 parts of products is by 40 parts in Radix Rehmanniae Preparata, 40 parts in the Radix Rehmanniae, 45 parts of the Radixs Astragali, 25 parts of Radix Ginseng Rubra, 25 parts of Radix Codonopsis, 15 parts of Hippocampus, 20 parts of Herba Cistanches, 20 parts of Fructus Lycii, 20 parts of Semen Cuscutae, 25 parts of Fructus Corni, 25 parts of Radix Morindae Officinaliss, 20 parts of Herba Epimedii, 15 parts of Rhizoma Curculiginises, 15 parts of Rhizoma Dioscoreaes, 15 parts of Cortex Cinnamomis, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Radixs Polygoni Multiflori, 20 parts of the Radix Paeoniae Albas, 25 parts of Cortex Moutans, 25 parts of Pericarpium Citri Reticulataes, 25 parts in Colla Corii Asini, 25 parts of Cortex Lycii, 25 parts of Fructus Gardeniaes, 15 parts of pollen, 15 parts of the Rhizoma Anemarrhenaes, 15 parts of Carapax et Plastrum Testudiniss, 25 parts of Fructus Psoraleaes, 40 parts of Os Draconis, 40 parts of Concha Ostreaes, behind the indispensable good raw material of the parts by weight of the Mel of 20 parts in Radix Glycyrrhizae and surplus, other raw material mix homogeneously that will be except that Mel, be ground into fine powder, Mel is put into container made of iron, be heated to boiling, other raw material that is ground into fine powder is added in the ebullient Mel, stir, make pill.
By per 1000 parts of products is by 50 parts in Radix Rehmanniae Preparata, 50 parts in the Radix Rehmanniae, 50 parts of the Radixs Astragali, 30 parts of Radix Ginseng Rubra, 30 parts of Radix Codonopsis, 20 parts of Hippocampus, 30 parts of Herba Cistanches, 30 parts of Fructus Lycii, 30 parts of Semen Cuscutae, 30 parts of Fructus Corni, 30 parts of Radix Morindae Officinaliss, 30 parts of Herba Epimedii, 20 parts of Rhizoma Curculiginises, 30 parts of Rhizoma Dioscoreaes, 20 parts of Cortex Cinnamomis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of the Radixs Polygoni Multiflori, 30 parts of the Radix Paeoniae Albas, 30 parts of Cortex Moutans, 30 parts of Pericarpium Citri Reticulataes, 30 parts in Colla Corii Asini, 30 parts of Cortex Lycii, 30 parts of Fructus Gardeniaes, 20 parts of pollen, 20 parts of the Rhizoma Anemarrhenaes, 20 parts of Carapax et Plastrum Testudiniss, 30 parts of Fructus Psoraleaes, 50 parts of Os Draconis, 50 parts of Concha Ostreaes, behind the indispensable good raw material of the parts by weight of the Mel of 30 parts in Radix Glycyrrhizae and surplus, other raw material mix homogeneously that will be except that Mel, be ground into fine powder, Mel is put into container made of iron, be heated to boiling, other raw material that is ground into fine powder is added in the ebullient Mel, stir, make pill.
Claims (2)
1. Chinese medicine for the treatment of aplastic anemia, it is characterized in that: per 1000 parts of products are by Radix Rehmanniae Preparata 40-50 part, Radix Rehmanniae 40-50 part, Radix Astragali 45-50 part, Radix Ginseng Rubra 25-30 part, Radix Codonopsis 25-30 part, Hippocampus 15-20 part, Herba Cistanches 20-30 part, Fructus Lycii 20-30 part, Semen Cuscutae 20-30 part, Fructus Corni 25-30 part, Radix Morindae Officinalis 25-30 part, Herba Epimedii 20-30 part, Rhizoma Curculiginis 15-20 part, Rhizoma Dioscoreae 15-30 part, Cortex Cinnamomi 15-20 part, Rhizoma Atractylodis Macrocephalae 15-30 part, Radix Polygoni Multiflori 15-30 part, Radix Paeoniae Alba 20-30 part, Cortex Moutan 25-30 part, Pericarpium Citri Reticulatae 25-30 part, Colla Corii Asini 25-30 part, Cortex Lycii 25-30 part, Fructus Gardeniae 25-30 part, pollen 15-20 part, Rhizoma Anemarrhenae 15-20 part, Carapax et Plastrum Testudinis 15-20 part, Fructus Psoraleae 25-30 part, Os Draconis 40-50 part, Concha Ostreae 40-50 part, Radix Glycyrrhizae 20-30 part and surplus Mel are made, and related unit serving is weight portion.
2. manufacture method for the treatment of the Chinese medicine of aplastic anemia, it is characterized in that: by per 1000 parts of products is by Radix Rehmanniae Preparata 40-50 part, Radix Rehmanniae 40-50 part, Radix Astragali 45-50 part, Radix Ginseng Rubra 25-30 part, Radix Codonopsis 25-30 part, Hippocampus 15-20 part, Herba Cistanches 20-30 part, Fructus Lycii 20-30 part, Semen Cuscutae 20-30 part, Fructus Corni 25-30 part, Radix Morindae Officinalis 25-30 part, Herba Epimedii 20-30 part, Rhizoma Curculiginis 15-20 part, Rhizoma Dioscoreae 15-30 part, Cortex Cinnamomi 15-20 part, Rhizoma Atractylodis Macrocephalae 15-30 part, Radix Polygoni Multiflori 15-30 part, Radix Paeoniae Alba 20-30 part, Cortex Moutan 25-30 part, Pericarpium Citri Reticulatae 25-30 part, Colla Corii Asini 25-30 part, Cortex Lycii 25-30 part, Fructus Gardeniae 25-30 part, pollen 15-20 part, Rhizoma Anemarrhenae 15-20 part, Carapax et Plastrum Testudinis 15-20 part, Fructus Psoraleae 25-30 part, Os Draconis 40-50 part, Concha Ostreae 40-50 part, behind the indispensable good raw material of the parts by weight of Radix Glycyrrhizae 20-30 part and surplus Mel, other raw material mix homogeneously that will be except that Mel, be ground into fine powder, Mel is put into container made of iron, be heated to boiling, other raw material that is ground into fine powder is added in the ebullient Mel, stir, make pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100096334A CN100411659C (en) | 2006-01-18 | 2006-01-18 | Chinese medicine for treating aplastic anemia and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100096334A CN100411659C (en) | 2006-01-18 | 2006-01-18 | Chinese medicine for treating aplastic anemia and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1840040A CN1840040A (en) | 2006-10-04 |
| CN100411659C true CN100411659C (en) | 2008-08-20 |
Family
ID=37029343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100096334A Expired - Fee Related CN100411659C (en) | 2006-01-18 | 2006-01-18 | Chinese medicine for treating aplastic anemia and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100411659C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361858B (en) * | 2008-09-28 | 2011-04-06 | 袁六妮 | Medicine for treating aplastic anemia |
| CN102727707A (en) * | 2011-04-14 | 2012-10-17 | 张建民 | Pharmaceutical composition for treating leukemia and aplastic anemia |
| CN102824506B (en) * | 2012-09-19 | 2013-12-04 | 肖太武 | Traditional Chinese medicine preparation for treating aplastic anemia |
| CN102988616B (en) * | 2012-11-21 | 2014-08-20 | 邓秀芝 | Chinese medicinal composition for treating anemia |
| CN103505679B (en) * | 2013-08-30 | 2015-05-20 | 杜丽娟 | Drug for treating blood diseases, preparation method, and applications thereof |
| CN103933203B (en) * | 2014-04-01 | 2015-10-28 | 陕西医大血友病研究院 | A kind of compound recipe Hematogenesis capsule being used for the treatment of aplastic anemia and preparation method thereof |
| CN106389764B (en) * | 2016-09-23 | 2019-10-08 | 浙江省中医院 | A kind of Chinese materia medica preparation and its preparation and application |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1162172C (en) * | 2001-12-04 | 2004-08-18 | 刘钦 | Baixue-Genzhi-Changshoubao-Chinese medicine for treating leukemia and concurrently treating aplastic anemia |
-
2006
- 2006-01-18 CN CNB2006100096334A patent/CN100411659C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1162172C (en) * | 2001-12-04 | 2004-08-18 | 刘钦 | Baixue-Genzhi-Changshoubao-Chinese medicine for treating leukemia and concurrently treating aplastic anemia |
Non-Patent Citations (2)
| Title |
|---|
| 中西药治疗再生障碍性贫血的临床研究. 刘艳萍等.时珍国医国药，第14卷第2期. 2003 |
| 中西药治疗再生障碍性贫血的临床研究. 刘艳萍等.时珍国医国药，第14卷第2期. 2003 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1840040A (en) | 2006-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1124153C (en) | Medicinal composition for restoring cardiac collaterals and its application | |
| CN100411659C (en) | Chinese medicine for treating aplastic anemia and preparation method thereof | |
| CN102178850B (en) | Medicament for treating headache | |
| CN1166394C (en) | Chinese medicine for treating pharyngitis and globus hystericus and its prepn | |
| CN101259190A (en) | Chinese medicine assembly for warming kidney, compensating spleen, benefitting qi and nourishing blood and preparation thereof | |
| CN101455791A (en) | Pure traditional Chinese medicine preparation for treating hyperlipemia | |
| CN1120010C (en) | Scrophularia capsule and its preparing process | |
| CN104436148A (en) | Traditional Chinese medicine composition for treating hypotension caused by qi-blood deficiency | |
| CN101264220A (en) | Medicaments assembly for tonifying kidney and invigorating spleen, activating blood circulation and removing stasis and preparation thereof | |
| CN102008391B (en) | Method for solidifying traditional Chinese ointment | |
| CN102441115A (en) | Traditional Chinese medicine composition for treating alopecia | |
| CN104758536A (en) | Traditional Chinese medicine warm paste used for warming woman's womb and preparation technology thereof | |
| CN1164317C (en) | Zaizao Pill for treating woman diseases | |
| CN1088371C (en) | Hair-blackening and hair-growing capsule and its preparation method | |
| CN101884761A (en) | Medicament for treating cirrhosis and portal hypertension | |
| CN103100021A (en) | Pharmaceutical composition for tonifying spleen and stomach and method for preparing same | |
| CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
| CN104383461A (en) | Chinese medicinal composition for treating insomnia due to blood stasis | |
| CN101757312A (en) | Chinese medicine preparation for treating thrombocytopenia | |
| CN101062347A (en) | Chinese traditional medicine formula good for heart and brain | |
| CN1408383A (en) | Pure traditional Chinese medicine preparation for curing gastroinstestinal cancer and preparing method | |
| CN1634213A (en) | Chinese medicinal formulation for hematogenesis | |
| CN102366543A (en) | Chinese herbal medicine for treating blood deficiency, blood heat and blood dryness | |
| CN101757254A (en) | Traditional Chinese medicine preparation for preventing and curing postpartum alopecia | |
| CN101683446A (en) | Traditional Chinese medicine composition with function of invigorating circulation and reducing blood fat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080820 Termination date: 20110118 |